Smith & Nephew wraps up $330m purchase of Israeli medtech firm CartiHeal

10th Jan 2024 07:27

(Sharecast News) - Medtech giant Smith + Nephew has completed the acquisition of CartiHeal, the developer of novel sports medicine technology Agili-C, which targets cartilage regeneration in the knee.

Read more

Smith & Nephew names new audit committee lead

6th Dec 2023 07:47

(Sharecast News) - Smith & Nephew has announced that non-executive director Rick Medlock has decided to step down after three years at the medical technology group.

Read more

Goldman starts Smith & Nephew at 'buy', cites improving fundamentals

10th Nov 2023 09:36

(Sharecast News) - Goldman Sachs initiated coverage of Smith & Nephew on Friday with a 'buy' rating and 1,400p price target, as it pointed to improving fundamentals and an undemanding valuation.

Read more

JPMorgan upgrades Smith & Nephew, says recent de-rating 'overdone'

3rd Nov 2023 09:19

(Sharecast News) - JPMorgan Cazenove upgraded Smith & Nephew to 'overweight' from 'neutral' on Friday as it argued the recent de-rating was overdone.

Read more

London close: Stocks rise as BoE keeps rates steady

2nd Nov 2023 15:12

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Smith & Nephew expects strong full-year results after solid Q3

2nd Nov 2023 07:20

(Sharecast News) - Smith & Nephew has said that sales growth is now expected to be at the top end of guidance after a strong third quarter, though it did warn that margins would likely not grow as much as hoped.

Read more

Broker tips: Antofagasta, Spirax-Sarco, Smith & Nephew

10th Aug 2023 12:01

(Sharecast News) - Canaccord Genuity has maintained its 'buy' recommendation on miner Antofagasta despite the firm cutting its output forecasts on Thursday.

Read more

Major upside potential at Smith & Nephew, says Berenberg

10th Aug 2023 11:07

(Sharecast News) - Berenberg has kept its 'buy' rating on Smith & Nephew after the medical equipment manufacturer's first-half results last week, giving an optimistic take on its current turnaround strategy.

Read more

Smith+Nephew lifts annual revenue guidance

3rd Aug 2023 07:33

(Sharecast News) - Medical products maker Smith+Nephew on Thursday lifted its full-year revenue outlook as first-half results were boosted by outperformance in its sports medicine and advanced wound management divisions.

Read more

Director dealings: Smith & Nephew executives offload shares

3rd May 2023 12:33

(Sharecast News) - Medical technology company Smith & Nephew disclosed two executive share sales on Wednesday, with its shares remaining flat after the announcement.

Read more

Smith & Nephew Q1 revenues grow, reiterates FY guidance

26th Apr 2023 08:05

(Sharecast News) - Medical equipment manufacturer Smith & Nephew reiterated its full-year guidance on Wednesday after seeing revenues improve in the first quarter.

Read more

Liberum upgrades Smith & Nephew to 'buy'

1st Mar 2023 14:05

(Sharecast News) - Liberum upgraded Smith & Nephew on Wednesday to 'buy' from 'hold' and hiked the price target to 1,410p from 1,120p, saying it would look to buy on dips given the recent run.

Read more

Smith & Nephew confident despite slip in profits

21st Feb 2023 07:23

(Sharecast News) - Medical technology company Smith & Nephew reported full-year revenue of $5.22bn (£4.35bn) on Tuesday, which was up 4.7% on an underlying basis year-on-year.

Read more

Smith+Nephew appoints former Serco CEO Soames as chair

17th Feb 2023 07:25

(Sharecast News) - Medical technology company Smith+Nephew said it had appointed former Serco chief executive Rupert Soames as chair, succeeding Roberto Quarta who will this year.

Read more

Smith & Nephew Q3 revenues touch lighter than expected

3rd Nov 2022 07:23

(Sharecast News) - Medical equipment maker Smith & Nephew posted slightly lower-than-expected third-quarter revenues on Thursday as it said revenue growth for the full year was set to be in the middle of the previously guided range.

Read more